Daiichi Sankyo takes oncology shift into next phase with new global business unit

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 23, 2020 at 10:42 PM.

  1. #1 cafead, Nov 23, 2020 at 10:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Daiichi Sankyo is taking another big step in its transformation to oncology drugmaker. The pharma company recently laid out plans to create an integrated oncology business unit, tapping current U.S. business chief Ken Keller to take the reins when it opens its doors on April 1.

    article source
     
    Quote

Reply to Thread